With the increase in drug counterfeiting, pharmaceutical industry and regulatory agencies are adopting multiple anti-counterfeit strategies such as new regulations, secured drug supply chains and heightened awareness among stakeholders. Secured supply chains require the ability to trace, validate and verify the authenticity of the drug at any stage of the supply chain (e-Pedigree regulation).